A 14-year-old from Surat needed a liver transplant due to advanced fatty liver disease, accelerated by junk food and genetic risk. Hepatologists urge urgent action on childhood obesity and diet.
ICMR study reveals disrupted sleep, chronic stress, and central obesity are key drivers of India's rising breast cancer burden, projected to add 50,000 cases yearly. Learn the risk factors.
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
A new study from Serbia finds most parents fail to recognise when their child is overweight, delaying crucial health interventions. Learn how to spot the signs and take action for your child's long-term wellbeing.
A new World Obesity Atlas warns 51% of the world will be overweight by 2035. Experts highlight higher cardiovascular risk for Asians at lower BMI. Learn about new drugs and safe weight management.
Discover how black cumin (kalonji), a staple in Indian kitchens, is backed by science for improving cholesterol, reducing fat cells, and supporting metabolic health. Learn easy ways to include it in your diet.
A landmark UNICEF report reveals a historic shift: more children globally are now obese than underweight. A new scientific review links this crisis and climate change to our food systems. Discover the connection and what we can do.
A new Harvard study uncovers how gut microbes signal the liver to influence metabolism, offering a novel holistic approach to managing type 2 diabetes and obesity. Read the breakthrough findings.
Medical experts in Bengaluru link economic growth & globalised fast food to a sharp rise in adolescent obesity, causing PCOD, diabetes & lifelong health issues. Learn the causes and solutions.
New research reveals that smells of fatty foods during pregnancy can rewire a baby's brain, increasing future risks of obesity and diabetes. Learn how to protect your child's health.
A 10-year PGI study finds 19% of Chandigarh residents developed diabetes. Central obesity, a 1.6 cm waist increase, triples risk. Learn how to protect yourself.
Loud snoring in men is often sleep apnea, a serious disorder linked to obesity. It raises risks of heart disease and diabetes. Experts urge timely diagnosis and weight management.
A major Lancet review reveals childhood hypertension has nearly doubled since 2000, affecting 4.3% of kids. Indian experts confirm the surge, linking it to junk food, screens, and stress. Learn the signs and why screening is crucial.
New research reveals popular cooking oils in India may contribute to obesity. Learn which oils are under scrutiny and discover healthier alternatives for your kitchen.
A 10-year-old Mumbai boy gained 10 kg in 5 months due to smartphone addiction. A new US study confirms early smartphone use raises risks of depression, obesity, and poor sleep in children. Learn how a psychologist helped him recover.
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
A new study finds low choline levels in obese young adults may be an early warning for future brain problems like Alzheimer's. Discover the vital nutrient's role and food sources to boost intake.
A 30-year-old Russian fitness trainer died from heart failure after consuming 10,000 calories daily. Learn the deadly risks of rapid weight gain and how to protect your heart.
The 'Ozempets' trend of using human weight-loss drugs like Ozempic on pets is growing. Experts warn of severe risks as these drugs are not approved for animals. Learn safe alternatives.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Eli Lilly reduces Zepbound's starting price to $299 monthly, intensifying its price war with Novo Nordisk's Ozempic and Wegovy. New discounts aim to expand access to blockbuster weight-loss drugs.
Essential UPSC updates: Govt's Sanchar Saathi app directive, GPS spoofing threats, WHO's obesity guidelines, fiscal federalism debate, and India's rare-earth push. Key insights for Prelims & Mains.
A landmark 14-year study reveals your neighbourhood significantly impacts your body weight. Discover how local food environments and walkability shape health outcomes in India and beyond.
Explore how berberine, a traditional Ayurvedic compound, supports weight management, improves insulin sensitivity, and regulates metabolism through scientific mechanisms like AMPK activation. Learn about its safe usage.
Dr. Deepak Bhat from Amritsar highlights the dangers of junk food for children, advocating for mindful eating and traditional diets to prevent obesity and chronic diseases. Learn key tips.
Eli Lilly's oral GLP-1 drug Orforglipron offers needle-free weight management with significant results in Phase 3 trials. Discover how this tablet alternative works.